Interventional cardiologists in Jefferson's Cardiac Catheterization Laboratory have pioneered some of the most advanced interventional alternatives to surgery for the treatment of coronary artery disease, including balloon angioplasty, excimer laser angioplasty and coronary artery stenting.
First in the Nation to Use Drug-Coated Stents to Treat Coronary Blockage
Since our latest clinical trial, which demonstrated the benefit of stents compared with balloon angioplasty, we have been at the forefront of other groundbreaking procedures such as intracoronary brachytherapy to treat recurrent blockage within stents. In fact, we were among the first in the U.S. to use drug-coated stents to treat coronary blockage.
Following coronary artery stenting, dual antiplatelet therapy is mandatory to prevent clot formation within the stent. An allergic reaction to one of these agents, clopidogrel, is not uncommon. However, Jefferson's Interventional Research team discovered that by treating these patients on a short-term basis with a combination of corticosteroids and antihistamines can alleviate symptoms of an allergic reaction, allowing patients to remain on the medication.